首页 › 公司 › ALPN
ALPINE IMMUNE SCIENCES, INC.（ALPN）高管持股异动
该公司内部人(高管 / 董事 / 10% 以上股东)向 SEC 申报的交易记录。
完整申报记录(含历史)
本站从 SEC EDGAR 收录的历史 Form 4 申报(共 113 条,以下为最近 100 条)。此区为完整数据档案,与上方带中文解读的精选申报分开呈现。
| 申报日 | 申报人 | 表单 | 类型 | 金额 | 净股数 |
|---|---|---|---|---|---|
| 2024-05-20 | Christopher Peetz | 4 | 回售予公司 | — | -1,900 股 |
| 2024-05-20 | James Paul Rickey | 4 | 回售予公司 | — | -5.8 万股 |
| 2024-05-20 | Natasha Hernday | 4 | 回售予公司 | — | — |
| 2024-05-20 | Peter A. Thompson | 4 | 回售予公司 | — | -268.0 万股 |
| 2024-05-20 | Remy Durand | 4 | 回售予公司 | — | -13.3 万股 |
| 2024-05-20 | Stanford L Peng | 4 | 回售予公司 | — | -34.4 万股 |
| 2024-05-20 | James N Topper | 4 | 回售予公司 | — | -282.9 万股 |
| 2024-05-20 | Decheng Capital China Life Sciences USD Fund III, L.P. | 4 | 回售予公司 | — | -831.8 万股 |
| 2024-05-20 | Ulrich Martin Fuhs | 4 | 回售予公司 | — | -3.0 万股 |
| 2024-05-20 | Jorn Drappa | 4 | 回售予公司 | — | — |
| 2024-05-20 | Robert E Conway | 4 | 回售予公司 | — | -5.0 万股 |
| 2024-05-20 | ORBIMED ADVISORS LLC | 4 | 要约收购处置 | — | -268.0 万股 |
| 2024-05-20 | Mitchell Gold | 4 | 回售予公司 | — | -273.6 万股 |
| 2024-05-10 | Stanford L Peng | 4 | 期权行权取得 | $66.9 万 | 27.2 万股 |
| 2024-05-10 | Ulrich Martin Fuhs | 4 | 期权行权取得 | $27.5 万 | 2.3 万股 |
| 2024-05-10 | Remy Durand | 4 | 期权行权取得 | $51.4 万 | 9.5 万股 |
| 2024-05-10 | Mitchell Gold | 4 | 期权行权取得 | $10.0 万 | 1.3 万股 |
| 2024-05-09 | James Paul Rickey | 4 | 期权行权取得 | $16.2 万 | 2.7 万股 |
| 2024-04-29 | James N Topper | 4 | 公开市场卖出 | $1,227 | 120.0 万股 |
| 2024-01-29 | James Paul Rickey | 4 | 公开市场卖出 | $275.1 万 | — |
| 2024-01-22 | Decheng Capital China Life Sciences USD Fund III, L.P. | 4 | 行权(价内) | $1572.9 万 | 123.5 万股 |
| 2024-01-22 | Xiangmin Cui | 4 | 行权(价内) | $1572.9 万 | 123.5 万股 |
| 2024-01-16 | Peter A. Thompson | 4 | 行权(价内) | $185.0 万 | 14.5 万股 |
| 2024-01-16 | ORBIMED ADVISORS LLC | 4 | 行权(价内) | $185.0 万 | 14.5 万股 |
| 2024-01-05 | Mitchell Gold | 4 | 获授予/取得 | — | 9.6 万股 |
| 2024-01-05 | James Paul Rickey | 4 | 获授予/取得 | — | 3.1 万股 |
| 2024-01-05 | Remy Durand | 4 | 获授予/取得 | — | 3.1 万股 |
| 2024-01-05 | Stanford L Peng | 4 | 获授予/取得 | — | 4.8 万股 |
| 2024-01-04 | James N Topper | 4 | 获授予/取得 | — | — |
| 2024-01-04 | Robert E Conway | 4 | 获授予/取得 | — | — |
| 2024-01-04 | Natasha Hernday | 4 | 获授予/取得 | — | — |
| 2024-01-04 | Christopher Peetz | 4 | 获授予/取得 | — | — |
| 2024-01-04 | Xiangmin Cui | 4 | 获授予/取得 | — | — |
| 2024-01-04 | Peter A. Thompson | 4 | 获授予/取得 | — | — |
| 2024-01-04 | Jorn Drappa | 4 | 获授予/取得 | — | — |
| 2023-12-29 | Peter A. Thompson | 4 | 公开市场卖出 | $2867.2 万 | -154.6 万股 |
| 2023-12-29 | Mitchell Gold | 4 | 公开市场卖出 | $94.9 万 | 2.6 万股 |
| 2023-12-29 | OrbiMed Genesis GP LLC | 4 | 公开市场卖出 | $2867.2 万 | -154.6 万股 |
| 2023-12-27 | Mitchell Gold | 4 | 公开市场卖出 | $186.1 万 | — |
| 2023-12-21 | James Paul Rickey | 4 | 公开市场卖出 | $29.2 万 | — |
| 2023-12-21 | Mitchell Gold | 4 | 公开市场卖出 | $4.8 万 | — |
| 2023-12-18 | James Paul Rickey | 4 | 公开市场卖出 | $112.1 万 | — |
| 2023-12-13 | James N Topper | 4 | 行权(价内) | $185.0 万 | 14.5 万股 |
| 2023-12-12 | Mitchell Gold | 4 | 公开市场卖出 | $203.8 万 | -10.9 万股 |
| 2023-12-06 | James Paul Rickey | 4 | 公开市场卖出 | $113.7 万 | — |
| 2023-12-01 | James Paul Rickey | 4 | 公开市场卖出 | $1.1 万 | — |
| 2023-11-14 | Xiangmin Cui | 4 | 公开市场买入 | $468.8 万 | 37.5 万股 |
| 2023-11-14 | Decheng Capital Global Healthcare Fund (Master), LP | 4 | 公开市场买入 | $468.8 万 | 37.5 万股 |
| 2023-11-08 | James Paul Rickey | 4 | 公开市场卖出 | $28.9 万 | -7,014 股 |
| 2023-10-04 | Wolfgang Dummer | 4 | 获授予/取得 | — | — |
| 2023-01-05 | Robert E Conway | 4 | 获授予/取得 | — | — |
| 2023-01-05 | Peter A. Thompson | 4 | 获授予/取得 | — | — |
| 2023-01-05 | Stanford L Peng | 4 | 获授予/取得 | — | — |
| 2023-01-05 | James N Topper | 4 | 获授予/取得 | — | — |
| 2023-01-05 | Xiangmin Cui | 4 | 获授予/取得 | — | — |
| 2023-01-05 | Andrew Seth Sandler | 4 | 获授予/取得 | — | — |
| 2023-01-05 | Christopher Peetz | 4 | 获授予/取得 | — | — |
| 2023-01-05 | James Paul Rickey | 4 | 获授予/取得 | — | — |
| 2023-01-05 | Jorn Drappa | 4 | 获授予/取得 | — | — |
| 2023-01-05 | Natasha Hernday | 4 | 获授予/取得 | — | — |
| 2023-01-05 | Mitchell Gold | 4 | 获授予/取得 | — | — |
| 2022-09-27 | Xiangmin Cui | 4 | 获授予/取得 | $1470.0 万 | 200.0 万股 |
| 2022-09-27 | Decheng Capital China Life Sciences USD Fund III, L.P. | 4 | 获授予/取得 | $1470.0 万 | 200.0 万股 |
| 2022-08-18 | Andrew Seth Sandler | 4 | 获授予/取得 | — | — |
| 2022-07-19 | Jorn Drappa | 4 | 获授予/取得 | — | — |
| 2022-07-19 | Jay Venkatesan | 4 | 期权行权取得 | $9,028 | 2.0 万股 |
| 2022-02-15 | FHM LIFE SCIENCES VIII, L.P. | 4 | 公开市场买入 | $80.0 万 | 11.3 万股 |
| 2022-01-06 | Stanford L Peng | 4 | 获授予/取得 | — | — |
| 2022-01-06 | Mitchell Gold | 4 | 获授予/取得 | — | — |
| 2022-01-06 | James Paul Rickey | 4 | 获授予/取得 | — | — |
| 2022-01-04 | Robert E Conway | 4 | 获授予/取得 | — | — |
| 2022-01-04 | Jay Venkatesan | 4 | 获授予/取得 | — | — |
| 2022-01-04 | James N Topper | 4 | 获授予/取得 | — | — |
| 2022-01-04 | Xiangmin Cui | 4 | 获授予/取得 | — | — |
| 2022-01-04 | Christopher Peetz | 4 | 获授予/取得 | — | — |
| 2022-01-04 | Peter A. Thompson | 4 | 获授予/取得 | — | — |
| 2022-01-04 | Natasha Hernday | 4 | 获授予/取得 | — | — |
| 2022-01-04 | James Paul Rickey | 4 | 公开市场卖出 | $23.7 万 | -1.7 万股 |
| 2021-09-27 | Christopher Peetz | 4/A | 公开市场买入 | $1.9 万 | 1,900 股 |
| 2021-09-27 | Robert E Conway | 4/A | 公开市场买入 | $15.1 万 | 1.5 万股 |
| 2021-09-24 | Robert E Conway | 4 | 公开市场卖出 | $15.1 万 | 1.5 万股 |
| 2021-09-24 | Christopher Peetz | 4 | 公开市场卖出 | $1.9 万 | 1,900 股 |
| 2021-09-23 | Robert E Conway | 4 | 公开市场买入 | $9.8 万 | 1.0 万股 |
| 2021-09-21 | Mitchell Gold | 4 | 公开市场卖出 | $421.3 万 | -44.5 万股 |
| 2021-09-21 | Jay Venkatesan | 4 | 公开市场卖出 | $376.0 万 | -40.0 万股 |
| 2021-09-21 | James N Topper | 4 | 回售予公司 | — | -120.0 万股 |
| 2021-09-21 | Xiangmin Cui | 4 | 公开市场买入 | $1450.0 万 | 154.3 万股 |
| 2021-09-21 | Alpine Bioventures, GP, LLC | 4 | 公开市场卖出 | $376.0 万 | -40.0 万股 |
| 2021-09-21 | ORBIMED ADVISORS LLC | 4 | 公开市场买入 | $950.0 万 | 101.1 万股 |
| 2021-09-21 | Decheng Capital Management III (Cayman), LLC | 4 | 公开市场买入 | $1450.0 万 | 154.3 万股 |
| 2021-09-21 | Peter A. Thompson | 4 | 公开市场买入 | $950.0 万 | 101.1 万股 |
| 2021-09-17 | Mitchell Gold | 4 | 公开市场卖出 | $10.3 万 | -1.0 万股 |
| 2021-06-29 | Mitchell Gold | 4 | 公开市场卖出 | $13.0 万 | -1.3 万股 |
| 2021-06-02 | Zelanna Goldberg | 4 | 获授予/取得 | — | — |
| 2021-05-21 | Mitchell Gold | 4 | 公开市场卖出 | $78.4 万 | -5.2 万股 |
| 2021-05-14 | Mitchell Gold | 4 | 公开市场卖出 | $23.2 万 | -2.0 万股 |
| 2021-04-23 | Jay Venkatesan | 4 | 期权行权取得 | $5.9 万 | 1.5 万股 |
| 2021-04-15 | Mitchell Gold | 4 | 公开市场卖出 | $20.6 万 | -2.0 万股 |
| 2021-03-08 | Mitchell Gold | 4 | 公开市场卖出 | $26.0 万 | -2.0 万股 |
| 2021-02-03 | Mitchell Gold | 4 | 公开市场卖出 | $24.6 万 | -2.0 万股 |
历史档案为按 SEC 数据集批量收录的申报记录,未逐条生成中文解读;金额 / 净股数由申报字段派生。完整原文以 SEC EDGAR 为准。
说明:此处的「内部人交易 / 高管持股异动」指公司内部人依法向 SEC 提交的 Form 3/4/5 持股披露,是合法的公开申报,
与「内幕交易」(利用未公开重大信息牟利的违法行为)是两回事,请勿混淆。